• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种科兴疫苗后再接种mRNA或灭活疫苗加强针个体的B细胞亚群:一项纵向研究

B Cell Subtypes in Individuals Received mRNA or Inactivated Vaccine Boosters After Fully Vaccinated with CoronaVac: A Longitudinal Study.

作者信息

Kuloğlu Zeynep Ece, Talay Zeynep Gülçe, Albayrak Özgür, Ergönül Önder, Can Füsun

机构信息

Koç University IsBank Research Center for Infectious Diseases (KUISCID), İstanbul, Türkiye.

Graduate School of Health Sciences, Koç University School of Medicine, İstanbul, Türkiye.

出版信息

Infect Dis Clin Microbiol. 2023 Sep 30;5(3):257-261. doi: 10.36519/idcm.2023.246. eCollection 2023 Sep.

DOI:10.36519/idcm.2023.246
PMID:38633562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10986697/
Abstract

In this study, we aimed to investigate the changes in the B cell subpopulations after homologous or heterologous COVID-19 boosters. Blood samples were collected after baseline (3-5 months after two doses of CoronaVac), 1 and 3 months after BNT162b2 (n=28 and n=6), and CoronaVac (n=7 and n=4) boosters. Peripheral blood mononuclear cells (PBMCs) were isolated and stained with B cell markers, the ratios of naïve (CD19+CD20+CD27-), memory (CD19+CD20+CD27+), memory B cells expressing IgG (CD19+CD20+CD27+IgG+), and effector memory B cells (CD19+CD20+CD27+CD38+) were identified with flow cytometry. Significantly higher expression of memory B cells was observed in one month with BNT162b2 (12.16% one month, 5.98% three months) and CoronaVac (14.18% one month, 9.00% three months) boosters. IgG expressing memory B cell expression was significantly higher with BNT162b2 than with CoronaVac booster in one month (22.70% and 13.95%, respectively). The ratio of effector B cells in the first month after CoronaVac booster (25.44%) was significantly higher than the BNT162b2 booster (9.90%, =0.0263).

摘要

在本研究中,我们旨在调查同源或异源新冠病毒加强针接种后B细胞亚群的变化。在基线(两剂科兴疫苗接种后3 - 5个月)、BNT162b2加强针接种后1个月和3个月(n = 28和n = 6)以及科兴疫苗加强针接种后1个月和3个月(n = 7和n = 4)采集血样。分离外周血单个核细胞(PBMC)并用B细胞标志物染色,通过流式细胞术鉴定幼稚(CD19 + CD20 + CD27 -)、记忆(CD19 + CD20 + CD27 +)、表达IgG的记忆B细胞(CD19 + CD20 + CD27 + IgG +)和效应记忆B细胞(CD19 + CD20 + CD27 + CD38 +)的比例。在接种BNT162b2(1个月时为12.16%,3个月时为5.98%)和科兴疫苗(1个月时为14.18%,3个月时为9.00%)加强针后的1个月观察到记忆B细胞表达显著更高。接种BNT162b2加强针后1个月,表达IgG的记忆B细胞表达显著高于接种科兴疫苗加强针(分别为22.70%和13.95%)。接种科兴疫苗加强针后第1个月效应B细胞的比例(25.44%)显著高于接种BNT162b2加强针(9.90%,P = 0.0263)。

相似文献

1
B Cell Subtypes in Individuals Received mRNA or Inactivated Vaccine Boosters After Fully Vaccinated with CoronaVac: A Longitudinal Study.接种科兴疫苗后再接种mRNA或灭活疫苗加强针个体的B细胞亚群:一项纵向研究
Infect Dis Clin Microbiol. 2023 Sep 30;5(3):257-261. doi: 10.36519/idcm.2023.246. eCollection 2023 Sep.
2
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies.智利科兴疫苗和加强针的血清学研究:抗 SARS-CoV-2 刺突抗体的免疫原性和持久性。
BMC Med. 2022 Jun 9;20(1):216. doi: 10.1186/s12916-022-02406-0.
3
Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia.在健康成年人中,全剂量与半剂量的 COVID-19 疫苗(ChAdOx1-S 或 BNT162b2)或 CoronaVac 作为加强针接种后的免疫原性和安全性:在印度尼西亚进行的一项随机、观察者设盲、对照试验。
Lancet Infect Dis. 2023 May;23(5):545-555. doi: 10.1016/S1473-3099(22)00800-3. Epub 2023 Jan 11.
4
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.奥密克戎 BA.1 特异性 T 细胞应答在香港接种科兴或辉瑞疫苗的成年人中的观察性队列研究。
Lancet Microbe. 2023 Jun;4(6):e418-e430. doi: 10.1016/S2666-5247(23)00006-X. Epub 2023 Apr 20.
5
Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months.3 个月时用灭活 COVID-19 疫苗进行异源和同源加强与 6 个月时用 BNT162b2 进行同源加强的比较。
JAMA Netw Open. 2022 Aug 1;5(8):e2226046. doi: 10.1001/jamanetworkopen.2022.26046.
6
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.同源和异源加强针对于灭活 SARS-CoV-2 疫苗的有效性:一项大规模前瞻性队列研究。
Lancet Glob Health. 2022 Jun;10(6):e798-e806. doi: 10.1016/S2214-109X(22)00112-7. Epub 2022 Apr 23.
7
Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients.低转换记忆 B 细胞与肾移植受者接种 SARS-CoV-2 疫苗加强针后无体液免疫反应相关。
Front Immunol. 2023 Oct 24;14:1202630. doi: 10.3389/fimmu.2023.1202630. eCollection 2023.
8
Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption.利妥昔单抗治疗中断后多发性硬化症患者对 SARS-CoV-2 mRNA 疫苗接种的免疫反应。
Front Immunol. 2023 Jul 27;14:1219560. doi: 10.3389/fimmu.2023.1219560. eCollection 2023.
9
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.BNT162b2 和 CoronaVac 新冠疫苗对奥密克戎 BA.2 亚谱系引起的 SARS-CoV-2 无症状和有症状感染的有效性:一项前瞻性队列研究。
Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12.
10
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.

本文引用的文献

1
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine.第三次接种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)mRNA疫苗后对奥密克戎反应性B细胞记忆的有效回忆
Cell. 2022 May 26;185(11):1875-1887.e8. doi: 10.1016/j.cell.2022.04.009. Epub 2022 Apr 8.
2
Effect of BTN162b2 and CoronaVac boosters on humoral and cellular immunity of individuals previously fully vaccinated with CoronaVac against SARS-CoV-2: A longitudinal study.BNT162b2 和科兴疫苗加强针对于既往全程接种科兴疫苗的个体针对 SARS-CoV-2 的体液和细胞免疫的影响:一项纵向研究。
Allergy. 2022 Aug;77(8):2459-2467. doi: 10.1111/all.15316. Epub 2022 May 2.
3
Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers.
医护人员接种两剂科兴新冠疫苗后接种 ChAdOx1 nCoV-19 加强针的免疫原性。
Vaccines (Basel). 2022 Jan 30;10(2):217. doi: 10.3390/vaccines10020217.
4
Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine.接种新冠灭活疫苗后针对 SARS-CoV-2 的动态 B 细胞和 T 细胞应答。
Clin Microbiol Infect. 2022 Mar;28(3):410-418. doi: 10.1016/j.cmi.2021.10.006. Epub 2021 Oct 26.
5
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.对感染后长达 8 个月的 SARS-CoV-2 进行免疫记忆评估。
Science. 2021 Feb 5;371(6529). doi: 10.1126/science.abf4063. Epub 2021 Jan 6.
6
Reactivation of IgG-switched memory B cells by BCR-intrinsic signal amplification promotes IgG antibody production.通过BCR内在信号放大激活IgG类别转换记忆B细胞可促进IgG抗体产生。
Nat Commun. 2015 Oct 13;6:8575. doi: 10.1038/ncomms9575.
7
Isolation of whole mononuclear cells from peripheral blood and cord blood.从外周血和脐带血中分离全单核细胞。
Curr Protoc Immunol. 2009 Apr;Chapter 7:7.1.1-7.1.8. doi: 10.1002/0471142735.im0701s85.
8
Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses.初始和记忆性人类B细胞增殖的内在差异作为增强二次免疫反应的一种机制。
J Immunol. 2003 Jan 15;170(2):686-94. doi: 10.4049/jimmunol.170.2.686.